During the past decade, CHU de Bordeaux conducted 657 clinical trials. In the 10-year time frame, 657 clinical trials started and 66 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 360 clinical trials started and 51 clinical trials were completed. i.e. 14.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU de Bordeaux" #1 sponsor was "University Hospital, Bordeaux" with 259 trials, followed by "Nantes University Hospital" with 35 trials sponsored, "University Hospital, Toulouse" with 31 trials sponsored, "University Hospital, Brest" with 15 trials sponsored and "Centre Hospitalier Universitaire de Saint Etienne" with 15 trials sponsored. Other sponsors include 513 different institutions and companies that sponsored additional 236 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de Bordeaux" #1 collaborator was "Ministry of Health, France" with 24 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 11 trials as a collaborator, "National Cancer Institute, France" with 7 trials as a collaborator, "University Hospital, Bordeaux" with 7 trials as a collaborator and "Assistance Publique - Hôpitaux de Paris" with 6 trials as a collaborator. Other collaborators include 484 different institutions and companies that were collaborators in the rest 403 trials.

According to Clinical.Site data, the most researched conditions in "CHU de Bordeaux" are "Stroke" (18 trials), "Multiple Sclerosis" (17 trials), "Alzheimer Disease" (11 trials), "Rheumatoid Arthritis" (11 trials) and "Cystic Fibrosis" (10 trials). Many other conditions were trialed in "CHU de Bordeaux" in a lesser frequency.

Most popular intervention types in "CHU de Bordeaux" are "Drug" (302 trials), "Other" (204 trials), "Device" (141 trials), "Procedure" (109 trials) and "Biological" (45 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (63 trials), "IVA" (8 trials), "placebo" (7 trials), "Blood sample" (5 trials) and "Dexamethasone" (5 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Bordeaux" are 802 trials for "All" genders, 46 trials for "Female" genders and 23 trials for "Male" genders.

Currently, there are NaN active trials in "CHU de Bordeaux". 24 are not yet recruiting, 230 are recruiting, 60 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 434 completed trials in CHU de Bordeaux, undefined suspended trials, and 51 terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Bordeaux, 16 "Phase 1" clinical trials were conducted, 130 "Phase 2" clinical trials and 168 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 39 trials, and there were also 272 trials that are defined as “Not Applicable".